MedTrace Logo

Hyperglucagonaemia in Patients With Type 2 Diabetes - Role of Glucagon Clearance

NCT02475421 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2018-10-15

No results posted yet for this study

Summary

The study aims to evaluate the elimination and degradation of glucagon in patients with type 2 diabetes compared to matched healthy subjects.

Conditions

Interventions

BIOLOGICAL

Glucagon

One hour glucagon-clamp followed by one hour of blood sampling

Sponsors & Collaborators

  • University of Copenhagen

    collaborator OTHER

  • European Foundation for the Study of Diabetes

    collaborator OTHER

  • University Hospital, Gentofte, Copenhagen

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-12-31
Completion
2017-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02475421 on ClinicalTrials.gov